Yonhap Infomax NewsMedical device firm Licensemedical and drug developer Inventera set to debut on KOSDAQ this week with offering prices at top of range following strong institutional demand, while no new IPO subscriptions scheduled
#YonhapInfomax #Licensemedical #Inventera #KOSDAQ #TechnologySpecialListing #IPO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=112618
#YonhapInfomax #Licensemedical #Inventera #KOSDAQ #TechnologySpecialListing #IPO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=112618
Licensemedical, Inventera to List on KOSDAQ This Week - No New IPO Subscriptions or Bookbuilding
Medical device firm Licensemedical and drug developer Inventera set to debut on KOSDAQ this week with offering prices at top of range following strong institutional demand, while no new IPO subscriptions scheduled